Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van Wezel

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
The Oncologist|October 28, 2020
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy RecommendationsBart Koopman, Harry J M Groen, Marjolijn J L Ligtenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2020
<i>IGLV3-21</i> is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signalingPalash C Maity, Mayas Bilal, Marvyn T Koning, et al.
Nature Genetics|November 2, 2010
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Victor Enciso-Mora, Peter Broderick, Yussanne Ma, et al.
HGG Advances|July 20, 2025
Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9Noah C Helderman, Ting Yang, Claire Palles, et al.
Blood Cancer Journal|April 29, 2025
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironmentRuben A L de Groen, Fleur A de Groot, Stefan Böhringer, et al.
Blood|August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosisAldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Scientific Reports|November 11, 2015
Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal CancerMaria N Timofeeva, Ben Kinnersley, Susan M Farrington, et al.
Cancer Cell|February 13, 2019
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor PhenotypeJudith E Grolleman, Richarda M de Voer, Fadwa A Elsayed, et al.
Human Molecular Genetics|August 30, 2008
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancerAlan M Pittman, Emily Webb, Luis Carvajal-Carmona, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
The Oncologist|October 28, 2020
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy RecommendationsBart Koopman, Harry J M Groen, Marjolijn J L Ligtenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2020
<i>IGLV3-21</i> is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signalingPalash C Maity, Mayas Bilal, Marvyn T Koning, et al.
Nature Genetics|November 2, 2010
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Victor Enciso-Mora, Peter Broderick, Yussanne Ma, et al.
HGG Advances|July 20, 2025
Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9Noah C Helderman, Ting Yang, Claire Palles, et al.
Blood Cancer Journal|April 29, 2025
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironmentRuben A L de Groen, Fleur A de Groot, Stefan Böhringer, et al.
Blood|August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosisAldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Scientific Reports|November 11, 2015
Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal CancerMaria N Timofeeva, Ben Kinnersley, Susan M Farrington, et al.
Cancer Cell|February 13, 2019
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor PhenotypeJudith E Grolleman, Richarda M de Voer, Fadwa A Elsayed, et al.
Human Molecular Genetics|August 30, 2008
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancerAlan M Pittman, Emily Webb, Luis Carvajal-Carmona, et al.
Pageof 22